scholarly article | Q13442814 |
P50 | author | John T Belisle | Q38548374 |
P2093 | author name string | P. J. Brennan | |
K. Takayama | |||
G. S. Besra | |||
V. D. Vissa | |||
T. Sievert | |||
P2860 | cites work | CLUSTAL V: improved software for multiple sequence alignment | Q29617279 |
P433 | issue | 5317 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell wall | Q128700 |
Mycobacterium tuberculosis | Q130971 | ||
P304 | page(s) | 1420–1422 | |
P577 | publication date | 1997-05-30 | |
P1433 | published in | Science | Q192864 |
P1476 | title | Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis | |
P478 | volume | 276 |
Q83231096 | -chlorination mediates protective and immunomodulatory effects of oxidized human plasma proteins |
Q63369522 | A FRET-Based Fluorogenic Trehalose Dimycolate Analogue for Probing Mycomembrane-Remodeling Enzymes of Mycobacteria |
Q98566962 | A Fluorogenic Trehalose Probe for Tracking Phagocytosed Mycobacterium tuberculosis |
Q41880977 | A Screen for Protein-Protein Interactions in Live Mycobacteria Reveals a Functional Link between the Virulence-Associated Lipid Transporter LprG and the Mycolyltransferase Antigen 85A. |
Q48938668 | A chemical reporter strategy for detecting and identifying O-mycoloylated proteins in Corynebacterium |
Q33876915 | A deficiency in arabinogalactan biosynthesis affects Corynebacterium glutamicum mycolate outer membrane stability |
Q46204274 | A group of low molecular weight (<30 kDa) antigens of heat-killed Mycobacterium tuberculosis H37Rv confer better protection against experimental tuberculosis in guinea pigs |
Q37682690 | A hydrolase of trehalose dimycolate induces nutrient influx and stress sensitivity to balance intracellular growth of Mycobacterium tuberculosis |
Q34760830 | A limited antigen-specific cellular response is sufficient for the early control of Mycobacterium tuberculosis in the lung but is insufficient for long-term survival |
Q37135418 | A multistage mycobacterium tuberculosis subunit vaccine LT70 including latency antigen Rv2626c induces long-term protection against tuberculosis |
Q37623403 | A mutant of Mycobacterium tuberculosis H37Rv that lacks expression of antigen 85A is attenuated in mice but retains vaccinogenic potential |
Q80156172 | A mycolyl transferase mutant of Rhodococcus equi lacking capsule integrity is fully virulent |
Q36001167 | A new piperidinol derivative targeting mycolic acid transport in Mycobacterium abscessus. |
Q24657992 | A new recombinant bacille Calmette-Guérin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers |
Q24554444 | A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis |
Q90339325 | A piperidinol-containing molecule is active against Mycobacterium tuberculosis by inhibiting the mycolic acid flippase activity of MmpL3 |
Q37897211 | A proteomic view of mycobacteria. |
Q38476599 | A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity |
Q51218390 | A silicon nitride ISFET based immunosensor for Ag85B detection of tuberculosis. |
Q44771625 | A simple immunomonitoring procedure for mRNA-loaded dendritic cell therapy |
Q90345626 | A standardized BioBrick toolbox for the assembly of sequences in mycobacteria |
Q41311649 | AG 85, a major secretion protein of Mycobacterium tuberculosis, can be identified in ancient bone |
Q92962372 | ATP-binding cassette (ABC) import systems of Mycobacterium tuberculosis: target for drug and vaccine development |
Q97521652 | Activation of M1 Macrophages in Response to Recombinant TB Vaccines With Enhanced Antimycobacterial Activity |
Q28486808 | Acyl-CoA carboxylases (accD2 and accD3), together with a unique polyketide synthase (Cg-pks), are key to mycolic acid biosynthesis in Corynebacterianeae such as Corynebacterium glutamicum and Mycobacterium tuberculosis |
Q90396081 | Adhesion molecules facilitate host-pathogen interaction & mediate Mycobacterium tuberculosis pathogenesis |
Q47606759 | An Antibacterial β-Lactone Kills Mycobacterium tuberculosis by Disrupting Mycolic Acid Biosynthesis |
Q34492775 | An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis |
Q28487572 | An increase in expression of a Mycobacterium tuberculosis mycolyl transferase gene (fbpB) occurs early after infection of human monocytes |
Q36368157 | An inhibitor of exported Mycobacterium tuberculosis glutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: extracellular proteins as potential novel drug targets |
Q42055684 | Analysis and modeling of mycolyl-transferases in the CMN group |
Q36296764 | Analysis of the complete genome sequence of Nocardia seriolae UTF1, the causative agent of fish nocardiosis: The first reference genome sequence of the fish pathogenic Nocardia species |
Q35554854 | Analysis of the genes encoding the antigen 85 complex and MPT51 from Mycobacterium avium |
Q38830420 | Antibiotic resistance mechanisms in M. tuberculosis: an update |
Q45075983 | Antigen 85A and mycobacterial DNA-binding protein 1 are targets of immunoglobulin G in individuals with past tuberculosis. |
Q35867371 | Antigen 85C inhibition restricts Mycobacterium tuberculosis growth through disruption of cord factor biosynthesis |
Q28486729 | Antigen 85C-mediated acyl-transfer between synthetic acyl donors and fragments of the arabinan |
Q34007982 | Antigen specificity of T-cell response to Mycobacterium avium infection in mice |
Q58840292 | Approaches to combat tuberculosis |
Q37970706 | Arabinogalactan and lipoarabinomannan biosynthesis: structure, biogenesis and their potential as drug targets. |
Q40312863 | Azido Pentoses: A New Tool To Efficiently Label Mycobacterium tuberculosis Clinical Isolates. |
Q35191900 | Bacterial virulence in the moonlight: multitasking bacterial moonlighting proteins are virulence determinants in infectious disease |
Q57217262 | Biochemical Characterization of Isoniazid-resistant Can the Analysis of Clonal Strains Reveal Novel Targetable Pathways? |
Q46611953 | Bioorthogonal Chemical Reporters for Selective In Situ Probing of Mycomembrane Components in Mycobacteria |
Q34283574 | Biosynthesis and translocation of unsulfated acyltrehaloses in Mycobacterium tuberculosis |
Q37142148 | Biosynthesis of D-arabinose in mycobacteria - a novel bacterial pathway with implications for antimycobacterial therapy |
Q36027530 | Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials |
Q30376072 | Boosting BCG-primed mice with chimeric DNA vaccine HG856A induces potent multifunctional T cell responses and enhanced protection against Mycobacterium tuberculosis. |
Q34007060 | Boosting vaccine for tuberculosis |
Q37387041 | Buruli ulcer disease: prospects for a vaccine |
Q35854792 | CD40 ligand enhances immunogenicity of vector-based vaccines in immunocompetent and CD4+ T cell deficient individuals |
Q92867274 | Cell Walls and Membranes of Actinobacteria |
Q30843747 | Cell wall structure of a mutant of Mycobacterium smegmatis defective in the biosynthesis of mycolic acids. |
Q37591593 | Chapter 2: Biogenesis of the cell wall and other glycoconjugates of Mycobacterium tuberculosis |
Q63369533 | Characterization of Tetrahydrolipstatin and Stereoderivatives on the Inhibition of Essential Mycobacterium tuberculosis Lipid Esterases |
Q43001474 | Characterization of a putative alpha-mannosyltransferase involved in phosphatidylinositol trimannoside biosynthesis in Mycobacterium tuberculosis |
Q48328171 | Characterization of the cell surface protein gene of Corynebacterium ammoniagenes |
Q43693593 | Characterization of the in vivo acceptors of the mycoloyl residues transferred by the corynebacterial PS1 and the related mycobacterial antigens 85. |
Q41394328 | Characterization of the secreted chorismate mutase from the pathogen Mycobacterium tuberculosis |
Q89420594 | Chemoenzymatic Synthesis of Trehalosamine, an Aminoglycoside Antibiotic and Precursor to Mycobacterial Imaging Probes |
Q93074501 | Chemoenzymatic radiosynthesis of 2-deoxy-2-[18F]fluoro-d-trehalose ([18F]-2-FDTre): A PET radioprobe for in vivo tracing of trehalose metabolism |
Q44692000 | Chemoenzymatic synthesis of trehalose analogues: rapid access to chemical probes for investigating mycobacteria |
Q95322518 | Clinically relevant mutations in mycobacterial LepA cause rifampicin-specific phenotypic resistance |
Q28486897 | Cloning and characterization of secretory tyrosine phosphatases of Mycobacterium tuberculosis |
Q33972807 | Combinatorial use of antibodies to secreted mycobacterial proteins in a host immune system-independent test for tuberculosis |
Q41592018 | Commensal Streptococcus mitis is a unique vector for oral mucosal vaccination |
Q35756648 | Comparative cell wall core biosynthesis in the mycolated pathogens, Mycobacterium tuberculosis and Corynebacterium diphtheriae |
Q36226487 | Comparative metabolic profiling of mce1 operon mutant vs wild-type Mycobacterium tuberculosis strains |
Q34290885 | Comparison of BCG prime-DNA booster and rBCG regimens for protection against tuberculosis |
Q54204073 | Compartment-Specific Labeling of Bacterial Periplasmic Proteins by Peroxidase-Mediated Biotinylation. |
Q47105089 | Comprehensive transcriptome analysis reveals distinct regulatory programs during vernalization and floral bud development of orchardgrass (Dactylis glomerata L.). |
Q28486866 | Conditional sigma factor expression, using the inducible acetamidase promoter, reveals that the Mycobacterium tuberculosis sigF gene modulates expression of the 16-kilodalton alpha-crystallin homologue |
Q43459073 | Confrontation between intracellular bacteria and the immune system. |
Q36314798 | Control of cell wall assembly by a histone-like protein in Mycobacteria |
Q41619575 | Controlling Extra- and Intramacrophagic Mycobacterium abscessus by Targeting Mycolic Acid Transport |
Q36845494 | Cord formation in a clinical isolate of Mycobacterium marinum |
Q36749299 | Crystal structure of the Mycobacterium tuberculosis transcriptional regulator Rv0302 |
Q28087077 | Current efforts and future prospects in the development of live mycobacteria as vaccines |
Q38151469 | Current knowledge on mycolic acids in Corynebacterium glutamicum and their relevance for biotechnological processes |
Q34768541 | Current status and future development of antitubercular chemotherapy |
Q28487352 | Cutinase-like proteins of Mycobacterium tuberculosis: characterization of their variable enzymatic functions and active site identification |
Q48550005 | Cyclipostins and Cyclophostin analogs inhibit the antigen 85C from Mycobacterium tuberculosis both in vitro and in vivo. |
Q35758746 | DNA-Launched Alphavirus Replicons Encoding a Fusion of Mycobacterial Antigens Acr and Ag85B Are Immunogenic and Protective in a Murine Model of TB Infection |
Q22122411 | Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence |
Q36255711 | Defining mycobacteria: Shared and specific genome features for different lifestyles |
Q33220238 | Deletion of Cg-emb in corynebacterianeae leads to a novel truncated cell wall arabinogalactan, whereas inactivation of Cg-ubiA results in an arabinan-deficient mutant with a cell wall galactan core |
Q33856485 | Demonstration of components of antigen 85 complex in cerebrospinal fluid of tuberculous meningitis patients |
Q64990202 | Dendritic cell vaccine with Ag85A enhances anti-colorectal carcinoma immunity. |
Q40563393 | Deoxyfluoro-d-trehalose (FDTre) analogues as potential PET probes for imaging mycobacterial infection |
Q34033265 | Description of a novel adhesin of Mycobacterium avium subsp. paratuberculosis |
Q36543277 | Design, synthesis, and X-ray analysis of a glycoconjugate bound to Mycobacterium tuberculosis antigen 85C. |
Q35791774 | Developing an improved vaccine against tuberculosis |
Q45755895 | Development of CD8+ T cells expressing two distinct receptors specific for MTB and HIV-1 peptides. |
Q37844882 | Development of vaccines against tuberculosis |
Q33290345 | Diagnosis of tuberculosis in an Indian population by an indirect ELISA protocol based on detection of Antigen 85 complex: a prospective cohort study. |
Q34623344 | Differential cellular recognition pattern to M. tuberculosis targets defined by IFN-γ and IL-17 production in blood from TB + patients from Honduras as compared to health care workers: TB and immune responses in patients from Honduras |
Q28478254 | Discovery of novel MDR-Mycobacterium tuberculosis inhibitor by new FRIGATE computational screen |
Q63647673 | Discovery of trehalose phospholipids reveals functional convergence with mycobacteria |
Q28486461 | Disruption of the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis H37Rv: effect on growth in culture and in macrophages |
Q42373964 | Dissecting the mycobacterial cell envelope and defining the composition of the native mycomembrane |
Q41764612 | Docking of phosphonate and trehalose analog inhibitors into M. tuberculosis mycolyltransferase Ag85C: Comparison of the two scoring fitness functions GoldScore and ChemScore, in the GOLD software |
Q64097385 | Dynamics of Mycobacterium tuberculosis Ag85B Revealed by a Sensitive Enzyme-Linked Immunosorbent Assay |
Q37287828 | Early T-cell responses in tuberculosis immunity |
Q34003715 | Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode |
Q36596170 | Elastin, a novel extracellular matrix protein adhering to mycobacterial antigen 85 complex |
Q34242596 | Elucidation and chemical modulation of sulfolipid-1 biosynthesis in Mycobacterium tuberculosis |
Q42967332 | Elucidation of a protein-protein interaction network involved in Corynebacterium glutamicum cell wall biosynthesis as determined by bacterial two-hybrid analysis |
Q34568947 | Emerging therapeutic targets in tuberculosis: post-genomic era. |
Q53472728 | Endoplasmic reticulum stress response is involved in Mycobacterium tuberculosis protein ESAT-6-mediated apoptosis. |
Q33389187 | Enhanced and enduring protection against tuberculosis by recombinant BCG-Ag85C and its association with modulation of cytokine profile in lung |
Q84384783 | Enhanced protection against tuberculosis by vaccination with recombinant BCG over-expressing HspX protein |
Q57827848 | Enhancement of the human T cell response to culture filtrate fractions of Mycobacterium tuberculosis by microspheres |
Q33885084 | Enzymatic hydrolysis of trehalose dimycolate releases free mycolic acids during mycobacterial growth in biofilms |
Q83139710 | Epitope based recombinant BCG vaccine elicits specific Th1 polarized immune responses in BALB/c mice |
Q36511211 | Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection |
Q33755534 | Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis |
Q31055916 | Evidence for a partial redundancy of the fibronectin-binding proteins for the transfer of mycoloyl residues onto the cell wall arabinogalactan termini of Mycobacterium tuberculosis |
Q36297481 | Evolution of Mycolic Acid Biosynthesis Genes and Their Regulation during Starvation in Mycobacterium tuberculosis |
Q36305447 | Exploring Covalent Allosteric Inhibition of Antigen 85C from Mycobacterium tuberculosis by Ebselen Derivatives |
Q36558993 | Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization |
Q64084941 | Exploring the Potential Role of Moonlighting Function of the Surface-Associated Proteins From BCG Moreau and Pasteur by Comparative Proteomic |
Q46022626 | Export of recombinant Mycobacterium tuberculosis superoxide dismutase is dependent upon both information in the protein and mycobacterial export machinery. A model for studying export of leaderless proteins by pathogenic mycobacteria. |
Q34312082 | Exposure to a cutinase-like serine esterase triggers rapid lysis of multiple mycobacterial species |
Q54597128 | Expression levels of Mycobacterium tuberculosis antigen-encoding genes versus production levels of antigen-specific T cells during stationary level lung infection in mice. |
Q48284512 | Extracytoplasmic function sigma factor σD confers resistance to environmental stress by enhancing mycolate synthesis and modifying peptidoglycan structures in Corynebacterium glutamicum |
Q36010543 | Factors influencing the immune response to foreign antigen expressed in recombinant BCG vaccines |
Q33223435 | FbpA-Dependent biosynthesis of trehalose dimycolate is required for the intrinsic multidrug resistance, cell wall structure, and colonial morphology of Mycobacterium smegmatis |
Q34120576 | Fibronectin facilitates Mycobacterium tuberculosis attachment to murine alveolar macrophages |
Q37778852 | Fibronectin: a multidomain host adhesin targeted by bacterial fibronectin-binding proteins |
Q36546276 | Flagellin Encoded in Gene-Based Vector Vaccines Is a Route-Dependent Immune Adjuvant |
Q50748684 | Fluorescent phospholipid analogs as microscopic probes for detection of the mycolic acid-containing layer in Corynebacterium glutamicum: detecting alterations in the mycolic acid-containing layer following ethambutol treatment. |
Q57217294 | Fractionation and Analysis of Mycobacterial Proteins |
Q38996602 | Fragment-based approaches to TB drugs |
Q50855542 | Functional insights from a comparative study on the dynamics of Antigen85 proteins and MPT51 from Mycobacterium tuberculosis. |
Q38085081 | Functional, biochemical and 3D studies of Mycobacterium tuberculosis protein peptides for an effective anti-tuberculosis vaccine. |
Q28487466 | Galactan biosynthesis in Mycobacterium tuberculosis. Identification of a bifunctional UDP-galactofuranosyltransferase |
Q35140304 | Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adults |
Q33857535 | Generation of Monoclonal Antibodies against Ag85A Antigen of Mycobacterium tuberculosis and Application in a Competitive ELISA for Serodiagnosis of Bovine Tuberculosis |
Q34628570 | Genetics of Capsular Polysaccharides and Cell Envelope (Glyco)lipids |
Q46350642 | Green Fluorescent Protein as a protein localization and topological reporter in mycobacteria |
Q35758597 | Hairpin extensions enhance the efficacy of mycolyl transferase-specific antisense oligonucleotides targeting Mycobacterium tuberculosis. |
Q39995063 | Heterologous boosting of recombinant adenoviral prime immunization with a novel vesicular stomatitis virus-vectored tuberculosis vaccine |
Q35205962 | Heterologous expression of the Mycobacterium tuberculosis gene encoding antigen 85A in Corynebacterium glutamicum |
Q36221447 | High-throughput Identification of DNA-Encoded IgG Ligands that Distinguish Active and Latent Mycobacterium tuberculosis Infections |
Q37251573 | Human CD8(+) T cells transduced with an additional receptor bispecific for both Mycobacterium tuberculosis and HIV-1 recognize both epitopes. |
Q35132017 | Human immunity to M. tuberculosis: T cell subsets and antigen processing |
Q34165767 | IL-10 and NOS2 modulate antigen-specific reactivity and nerve infiltration by T cells in experimental leprosy |
Q43740030 | Identification of HLA-DR4-restricted T-cell epitope on MPT51 protein, a major secreted protein derived from Mycobacterium tuberculosis using MPT51 overlapping peptides screening and DNA vaccination |
Q27679091 | Identification of a Mycoloyl Transferase Selectively Involved in O-Acylation of Polypeptides in Corynebacteriales |
Q58040456 | Identification of a Novel Arabinofuranosyltransferase AftB Involved in a Terminal Step of Cell Wall Arabinan Biosynthesis in Corynebacterianeae, such asCorynebacterium glutamicumandMycobacterium tuberculosis |
Q37451434 | Identification of a stress-induced factor of Corynebacterineae that is involved in the regulation of the outer membrane lipid composition |
Q33315752 | Identification of an HLA-A*0201-restricted T-cell epitope on the MPT51 protein, a major secreted protein derived from Mycobacterium tuberculosis, by MPT51 overlapping peptide screening |
Q28486750 | Identification of an alpha(1-->6) mannopyranosyltransferase (MptA), involved in Corynebacterium glutamicum lipomanann biosynthesis, and identification of its orthologue in Mycobacterium tuberculosis |
Q92463453 | Identification of antigens presented by MHC for vaccines against tuberculosis |
Q30428990 | Identification of distant co-evolving residues in antigen 85C from Mycobacterium tuberculosis using statistical coupling analysis of the esterase family proteins |
Q28486448 | Identification of genes encoding exported Mycobacterium tuberculosis proteins using a Tn552'phoA in vitro transposition system |
Q31080718 | Identification of murine H2-Dd- and H2-Ab-restricted T-cell epitopes on a novel protective antigen, MPT51, of Mycobacterium tuberculosis |
Q43230400 | Identification of promoter-binding proteins of the fbp A and C genes in Mycobacterium tuberculosis |
Q38366006 | Illumination of growth, division and secretion by metabolic labeling of the bacterial cell surface |
Q50117423 | Imaging Mycobacterial Trehalose Glycolipids |
Q52716127 | Imaging mycobacterial growth and division with a fluorogenic probe. |
Q36628376 | Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations |
Q53644393 | Immunization with dendritic cells retrovirally transduced with mycobacterial antigen 85A gene elicits the specific cellular immunity including cytotoxic T-lymphocyte activity specific to an epitope on antigen 85A. |
Q35361654 | Immunodiagnosis of tuberculosis: a dynamic view of biomarker discovery |
Q34726923 | Immunogenicity and protective efficacy against murine tuberculosis of a prime-boost regimen with BCG and a DNA vaccine expressing ESAT-6 and Ag85A fusion protein. |
Q35915369 | Immunogenicity and protective efficacy of a novel recombinant BCG strain overexpressing antigens Ag85A and Ag85B. |
Q34085461 | Immunogenicity of a recombinant Mycobacterium smegmatis vaccine expressing the fusion protein CMX in cattle from Goiás State, Brazil. |
Q73774133 | Immunogenicity of recombinant BCG vaccine strains overexpressing components of the antigen 85 complex of Mycobacterium tuberculosis |
Q59356868 | Immunological association of inducible bronchus-associated lymphoid tissue organogenesis in Ag85B-rHPIV2 vaccine-induced anti-tuberculosis mucosal immune responses in mice |
Q37166275 | Immunological diversity within a family of cutinase-like proteins of Mycobacterium tuberculosis |
Q40867776 | Immunological requirements for a subunit vaccine against tuberculosis |
Q57209258 | Impact of MHC class I alleles on the M. tuberculosis antigen-specific CD8+ T-cell response in patients with pulmonary tuberculosis |
Q52688716 | Impact of the epoxide hydrolase EphD on the metabolism of mycolic acids in mycobacteria. |
Q57598511 | Impfung gegen Tuberkulose |
Q34007261 | Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting |
Q33324374 | Improved protective efficacy of a species-specific DNA vaccine encoding mycolyl-transferase Ag85A from Mycobacterium ulcerans by homologous protein boosting |
Q27684704 | Inactivation of the Mycobacterium tuberculosis Antigen 85 Complex by Covalent, Allosteric Inhibitors |
Q28486853 | Inactivation of the antigen 85C gene profoundly affects the mycolate content and alters the permeability of the Mycobacterium tuberculosis cell envelope |
Q39384014 | Indolcarboxamide is a preclinical candidate for treating multidrug-resistant tuberculosis |
Q37117196 | Induction of protective cellular immunity against Mycobacterium tuberculosis by recombinant attenuated self-destructing Listeria monocytogenes strains harboring eukaryotic expression plasmids for antigen 85 complex and MPB/MPT51 |
Q39707366 | Inhibition of Mycobacterium tuberculosis glutamine synthetase as a novel antibiotic strategy against tuberculosis: demonstration of efficacy in vivo |
Q39543623 | Inhibition of Mycobacterium tuberculosis secretory serine protease blocks bacterial multiplication both in axenic culture and in human macrophages |
Q28487303 | Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane |
Q35152897 | Insights into the microbial degradation of rubber and gutta-percha by analysis of the complete genome of Nocardia nova SH22a |
Q27640213 | Insights into trehalose synthesis provided by the structure of the retaining glucosyltransferase OtsA |
Q35078736 | IpsA, a novel LacI-type regulator, is required for inositol-derived lipid formation in Corynebacteria and Mycobacteria |
Q44968570 | Liberation of soluble proteins from live and dead mycobacterial cells and the implications for pathogenicity of tubercle bacilli hypothesis |
Q35588375 | Lipid metabolism and Type VII secretion systems dominate the genome scale virulence profile of Mycobacterium tuberculosis in human dendritic cells |
Q64886404 | Longitudinal Evaluation of Humoral Immunity and Bacterial and Clinical Parameters Reveals That Antigen-Specific Antibodies Suppress Inflammatory Responses in Active Tuberculosis Patients. |
Q33754481 | Mapping and identification of the major cell wall-associated components of Mycobacterium leprae |
Q34527217 | Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis |
Q47328162 | Measurement of sputum Mycobacterium tuberculosis messenger RNA as a surrogate for response to chemotherapy |
Q90399208 | Mechanical Forces between Mycobacterial Antigen 85 Complex and Fibronectin |
Q27680532 | Mechanism of inhibition of Mycobacterium tuberculosis antigen 85 by ebselen |
Q43181626 | Members of the 30- to 32-kilodalton mycolyl transferase family (Ag85) from culture filtrate of Mycobacterium avium subsp. paratuberculosis are immunodominant Th1-type antigens recognized early upon infection in mice and cattle |
Q33996832 | Microaerophilic induction of the alpha-crystallin chaperone protein homologue (hspX) mRNA of Mycobacterium tuberculosis |
Q64064017 | MmpL Proteins in Physiology and Pathogenesis of |
Q42189366 | MmpL genes are associated with mycolic acid metabolism in mycobacteria and corynebacteria |
Q37099803 | MmpL11 protein transports mycolic acid-containing lipids to the mycobacterial cell wall and contributes to biofilm formation in Mycobacterium smegmatis |
Q38170188 | MmpL3 a potential new target for development of novel anti-tuberculosis drugs |
Q92198241 | MmpL3 is a lipid transporter that binds trehalose monomycolate and phosphatidylethanolamine |
Q43796053 | Molecular approaches to tuberculosis |
Q38062402 | Molecular biology of drug resistance in Mycobacterium tuberculosis |
Q34014265 | Molecular mechanics of the mycobacterial cell wall: from horizontal layers to vertical scaffolds |
Q36777750 | Monoclonal antibodies to Mycobacterium tuberculosis CDC 1551 reveal subcellular localization of MPT51. |
Q59812478 | MtrA Response Regulator Controls Cell Division and Cell Wall Metabolism and Affects Susceptibility of Mycobacteria to the First Line Antituberculosis Drugs |
Q90689402 | MtrP, a putative methyltransferase in Corynebacteria, is required for optimal membrane transport of trehalose mycolates |
Q42692800 | Multiantigenic subunitary vaccines against tuberculosis in clinical trials: Where do we stand and where do we need to go? |
Q38782638 | Mycobacterial cell wall biosynthesis: a multifaceted antibiotic target |
Q34319337 | Mycobacterial trehalose dimycolate reprograms macrophage global gene expression and activates matrix metalloproteinases |
Q89667024 | Mycobacterial virulence: impact on immunogenicity and vaccine research |
Q37654644 | Mycobacterium tuberculosis Antigen 85A induces Th-1 immune responses in systemic sarcoidosis |
Q39331779 | Mycobacterium tuberculosis Mce1 protein complex initiates rapid induction of transcription of genes involved in substrate trafficking |
Q28474588 | Mycobacterium tuberculosis Rv3802c encodes a phospholipase/thioesterase and is inhibited by the antimycobacterial agent tetrahydrolipstatin |
Q44932638 | Mycobacterium tuberculosis antigen 85A and 85C structures confirm binding orientation and conserved substrate specificity |
Q35145725 | Mycobacterium tuberculosis gene expression in macrophages |
Q34137695 | Mycobacterium tuberculosis in the post-genomic age. |
Q24328798 | Mycobacterium tuberculosis malate synthase is a laminin-binding adhesin |
Q33855102 | Mycobacterium tuberculosis origin of replication and the promoter for immunodominant secreted antigen 85B are the targets of MtrA, the essential response regulator |
Q34213787 | Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence |
Q28487408 | Mycobacterium tuberculosis produces pili during human infection |
Q39663168 | Mycobacterium tuberculosis uptake by recipient host macrophages is influenced by environmental conditions in the granuloma of the infectious individual and is associated with impaired production of interleukin-12 and tumor necrosis factor alpha |
Q41627223 | Mycobacterium tuberculosis: bringing down the wall |
Q38541895 | Mycolic acids: deciphering and targeting the Achilles' heel of the tubercle bacillus |
Q28289888 | Mycolic acids: structure, biosynthesis and physiological functions |
Q49911385 | Mycolyltransferase from Mycobacterium tuberculosis in covalent complex with tetrahydrolipstatin provides insights into Antigen 85 catalysis. |
Q43252762 | Mycolyltransferase-mediated glycolipid exchange in Mycobacteria |
Q35209173 | Mycomembrane and S-layer: two important structures of Corynebacterium glutamicum cell envelope with promising biotechnology applications |
Q34609333 | Negligible genetic diversity of mycobacterium tuberculosis host immune system protein targets: evidence of limited selective pressure |
Q36057012 | New approaches to target the mycolic acid biosynthesis pathway for the development of tuberculosis therapeutics |
Q52551319 | New insights into the biogenesis of the cell envelope of corynebacteria: identification and functional characterization of five new mycoloyltransferase genes in Corynebacterium glutamicum. |
Q40216674 | New lipophilic phthalimido- and 3-phenoxybenzyl sulfonates: inhibition of antigen 85C mycolyltransferase activity and cytotoxicity |
Q39500970 | New virulence-activated and virulence-repressed genes identified by systematic gene inactivation and generation of transcriptional fusions in Bordetella pertussis. |
Q37264818 | No holes barred: invasion of the intestinal mucosa by Mycobacterium avium subsp. paratuberculosis |
Q35826779 | Novel GMO-Based Vaccines against Tuberculosis: State of the Art and Biosafety Considerations |
Q33994150 | Novel human recombinant antibodies against Mycobacterium tuberculosis antigen 85B |
Q35693993 | Novel mycobacteria antigen 85 complex binding motif on fibronectin |
Q51358092 | Novel potential diagnostic test for Mycobacterium tuberculosis complex using combined immunomagnetic separation (IMS) and PCR-CTPP. |
Q92854360 | Opportunities for Overcoming Mycobacterium tuberculosis Drug Resistance: Emerging Mycobacterial Targets and Host-Directed Therapy |
Q44863213 | Overexpression of proinflammatory TLR-2-signalling lipoproteins in hypervirulent mycobacterial variants |
Q28486871 | PapA1 and PapA2 are acyltransferases essential for the biosynthesis of the Mycobacterium tuberculosis virulence factor sulfolipid-1 |
Q34000178 | Pathophysiology of antigen 85 in patients with active tuberculosis: antigen 85 circulates as complexes with fibronectin and immunoglobulin G. |
Q28302775 | Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis |
Q33788061 | Peripheral blood and pleural fluid mononuclear cell responses to low-molecular-mass secretory polypeptides of Mycobacterium tuberculosis in human models of immunity to tuberculosis |
Q40101692 | Poly (lactide-co-glycolide) microspheres in respirable sizes enhance an in vitro T cell response to recombinant Mycobacterium tuberculosis antigen 85B. |
Q33199041 | Possible association of GroES and antigen 85 proteins with heat resistance of Mycobacterium paratuberculosis |
Q36485259 | Post-genomic vaccine development |
Q36247723 | Preclinical testing of new vaccines for tuberculosis: a comprehensive review |
Q28469010 | Prioritizing genomic drug targets in pathogens: application to Mycobacterium tuberculosis |
Q42466108 | Probing the mycobacterial trehalome with bioorthogonal chemistry |
Q36370092 | Processing of Mycobacterium tuberculosis antigen 85B involves intraphagosomal formation of peptide-major histocompatibility complex II complexes and is inhibited by live bacilli that decrease phagosome maturation |
Q36884506 | Progress in serodiagnosis of Mycobacterium tuberculosis infection |
Q35623341 | Prospects for vaccine development against Buruli disease |
Q24548647 | Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer |
Q46237973 | Proteomic analysis and immunogenicity of secreted proteins from Rhodococcus equi ATCC 33701. |
Q33877920 | Proteomic profile of culture filtrate from the Brazilian vaccine strain Mycobacterium bovis BCG Moreau compared to M. bovis BCG Pasteur |
Q53701664 | Rapid detection of Mycobacterium tuberculosis in sputum with a solvatochromic trehalose probe. |
Q42323219 | Rapid identification and drug susceptibility screening of ESAT-6 secreting Mycobacteria by a NanoELIwell assay |
Q84796471 | Rational design of multiple TB antigens TB10.4 and TB10.4-Ag85B as subunit vaccine candidates against Mycobacterium tuberculosis |
Q34310205 | Recombinant BCG vaccines |
Q38207991 | Recombinant BCG: Innovations on an Old Vaccine. Scope of BCG Strains and Strategies to Improve Long-Lasting Memory |
Q24675231 | Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model |
Q37983107 | Role of glycans and glycoproteins in disease development by Mycobacterium tuberculosis |
Q34491781 | Role of phagosomes and major histocompatibility complex class II (MHC-II) compartment in MHC-II antigen processing of Mycobacterium tuberculosis in human macrophages |
Q35867500 | SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis |
Q33468451 | Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A |
Q40068353 | Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trials |
Q28487174 | Secretion of an acid phosphatase (SapM) by Mycobacterium tuberculosis that is similar to eukaryotic acid phosphatases |
Q33998528 | Serodiagnostic potential of culture filtrate antigens of Mycobacterium tuberculosis |
Q37093875 | Serologic response to culture filtrate antigens of Mycobacterium ulcerans during Buruli ulcer disease |
Q92239592 | Serum antibody profiles in individuals with latent Mycobacterium tuberculosis infection |
Q57788796 | Significance of a histone-like protein with its native structure for the diagnosis of asymptomatic tuberculosis |
Q34942828 | Single nucleotide polymorphism in Ag85 genes of Mycobacterium tuberculosis complex: analysis of 178 clinical isolates from China and 13 BCG strains |
Q59291746 | Spray Drying Strategies to Stop Tuberculosis |
Q47745185 | Strategies to Improve Vaccine Efficacy against Tuberculosis by Targeting Innate Immunity |
Q36037140 | Synthesis and evaluation of new 2-aminothiophenes against Mycobacterium tuberculosis |
Q58606136 | Synthesis and in vitro characterization of trehalose-based inhibitors of mycobacterial trehalose 6-phosphate phosphatases |
Q90846009 | Synthesis of Long-Chain β-Lactones and Their Antibacterial Activities against Pathogenic Mycobacteria |
Q44154680 | Synthesis of glycosylated beta-amino acids as new class of antitubercular agents |
Q52219736 | Synthesis of mycolic acids of mycobacteria: an assessment of the cell-free system in light of the whole genome. |
Q33291869 | T-cell and serological responses to Erp, an exported Mycobacterium tuberculosis protein, in tuberculosis patients and healthy individuals |
Q33868122 | T-cell epitope mapping of the three most abundant extracellular proteins of Mycobacterium tuberculosis in outbred guinea pigs. |
Q47095995 | Tailoring Trehalose for Biomedical and Biotechnological Applications |
Q33292548 | Targeting fatty acid biosynthesis for the development of novel chemotherapeutics against Mycobacterium tuberculosis: evaluation of A-ring-modified diphenyl ethers as high-affinity InhA inhibitors |
Q34388246 | Targeting the Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex as a therapeutic strategy against tuberculosis: Proof of principle by using antisense technology. |
Q36561313 | Targeting the formation of the cell wall core of M. tuberculosis |
Q38056149 | Targeting the mycobacterial envelope for tuberculosis drug development |
Q36629840 | Targeting the trehalose utilization pathways of Mycobacterium tuberculosis |
Q44831422 | The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice |
Q40722193 | The Ag85B protein of the BCG vaccine facilitates macrophage uptake but is dispensable for protection against aerosol Mycobacterium tuberculosis infection |
Q33318121 | The Delta fbpA mutant derived from Mycobacterium tuberculosis H37Rv has an enhanced susceptibility to intracellular antimicrobial oxidative mechanisms, undergoes limited phagosome maturation and activates macrophages and dendritic cells |
Q44594937 | The Emb proteins of mycobacteria direct arabinosylation of lipoarabinomannan and arabinogalactan via an N‐terminal recognition region and a C‐terminal synthetic region |
Q26852552 | The Immunodominant T-Cell Epitopes of the Mycolyl-Transferases of the Antigen 85 Complex of M. tuberculosis |
Q60441795 | The LTK63 adjuvant improves protection conferred by Ag85B DNA-protein prime-boosting vaccination against Mycobacterium tuberculosis infection by dampening IFN-γ response |
Q58040682 | The M. tuberculosis antigen 85 complex and mycolyltransferase activity |
Q58123195 | The Mycobacterial Cell Envelope: A Relict From the Past or the Result of Recent Evolution? |
Q44400006 | The Mycobacterium tuberculosis Ag85A is a novel diacylglycerol acyltransferase involved in lipid body formation |
Q40211787 | The Mycobacterium tuberculosis MmpL11 Cell Wall Lipid Transporter Is Important for Biofilm Formation, Intracellular Growth, and Nonreplicating Persistence |
Q28486552 | The Mycobacterium tuberculosis PhoPR two-component system regulates genes essential for virulence and complex lipid biosynthesis |
Q22011039 | The PE-PGRS glycine-rich proteins of Mycobacterium tuberculosis: a new family of fibronectin-binding proteins? |
Q42728878 | The Rv3799-Rv3807 gene cluster in Mycobacterium tuberculosis genome corresponds to the 'Ancient Conserved Region' in CMN mycolyltransferases |
Q35195303 | The TB structural genomics consortium: a resource for Mycobacterium tuberculosis biology. |
Q24679239 | The complete genome of Rhodococcus sp. RHA1 provides insights into a catabolic powerhouse |
Q33215308 | The crucial role of trehalose and structurally related oligosaccharides in the biosynthesis and transfer of mycolic acids in Corynebacterineae |
Q42158453 | The domains of human fibronectin mediating the binding of alpha antigen, the most immunopotent antigen of mycobacteria that induces protective immunity against mycobacterial infection |
Q82271992 | The epidermis-specific extracellular BODYGUARD controls cuticle development and morphogenesis in Arabidopsis |
Q33960385 | The genetics and biochemistry of isoniazid resistance in mycobacterium tuberculosis. |
Q82535314 | The immunity and protective effects of antigen 85A and heat-shock protein X against progressive tuberculosis |
Q34657803 | The methyl-branched fortifications of Mycobacterium tuberculosis |
Q73109391 | The mycobacterial antigens 85 complex - from structure to function and beyond |
Q91287193 | The mycobacterial cell envelope - a moving target |
Q47829728 | The mycobacterial cell wall: structure, biosynthesis and sites of drug action. |
Q28487367 | The role of MmpL8 in sulfatide biogenesis and virulence of Mycobacterium tuberculosis |
Q28486838 | The role of RelMtb-mediated adaptation to stationary phase in long-term persistence of Mycobacterium tuberculosis in mice |
Q34888278 | The rv1184c locus encodes Chp2, an acyltransferase in Mycobacterium tuberculosis polyacyltrehalose lipid biosynthesis |
Q62607975 | The secretome of a recombinant BCG substrain reveals differences in hypothetical proteins |
Q34139044 | The three Mycobacterium tuberculosis antigen 85 isoforms have unique substrates and activities determined by non-active site regions |
Q46306114 | The trehalose-specific transporter LpqY-SugABC is required for antimicrobial and anti-biofilm activity of trehalose analogues in Mycobacterium smegmatis |
Q34200523 | The tuberculosis epidemic. Scientific challenges and opportunities |
Q28486736 | The two chorismate mutases from both Mycobacterium tuberculosis and Mycobacterium smegmatis: biochemical analysis and limited regulation of promoter activity by aromatic amino acids |
Q36301023 | Thermal and Photoinduced Copper-Promoted C-Se Bond Formation: Synthesis of 2-Alkyl-1,2-benzisoselenazol-3(2H)-ones and Evaluation against Mycobacterium tuberculosis |
Q46554089 | Three-step purification of lipopolysaccharide-free, polyhistidine-tagged recombinant antigens of Mycobacterium tuberculosis. |
Q108768030 | Toward Point-of-Care Detection of Mycobacterium tuberculosis: A Brighter Solvatochromic Probe Detects Mycobacteria within Minutes |
Q39917275 | Trehalose 6,6'-dimycolate on the surface of Mycobacterium tuberculosis modulates surface marker expression for antigen presentation and costimulation in murine macrophages |
Q38530356 | Trehalose Analogues: Latest Insights in Properties and Biocatalytic Production |
Q64110007 | Trehalose Conjugation Enhances Toxicity of Photosensitizers against Mycobacteria |
Q28486356 | Trehalose-recycling ABC transporter LpqY-SugA-SugB-SugC is essential for virulence of Mycobacterium tuberculosis |
Q38100476 | Tuberculosis diagnosis using immunodominant, secreted antigens of Mycobacterium tuberculosis. |
Q35873788 | Tuberculosis vaccine development: research, regulatory and clinical strategies |
Q92538784 | Underestimated Manipulative Roles of Mycobacterium tuberculosis Cell Envelope Glycolipids During Infection |
Q28731026 | Understanding communication signals during mycobacterial latency through predicted genome-wide protein interactions and boolean modeling |
Q33838182 | Uptake of unnatural trehalose analogs as a reporter for Mycobacterium tuberculosis |
Q61449163 | Utilization of Staphylococcal Immune Evasion Protein Sbi as a Novel Vaccine Adjuvant |
Q34120896 | Vaccination of guinea pigs with DNA encoding the mycobacterial antigen MPB83 influences pulmonary pathology but not hematogenous spread following aerogenic infection with Mycobacterium bovis |
Q27331427 | Vaccination with a BCG strain overexpressing Ag85B protects cattle against Mycobacterium bovis challenge |
Q33752344 | Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection |
Q35666220 | Vaccines displaying mycobacterial proteins on biopolyester beads stimulate cellular immunity and induce protection against tuberculosis |
Q38053069 | Virulence factors of the Mycobacterium tuberculosis complex |
Q36785897 | Zafirlukast inhibits complexation of Lsr2 with DNA and growth of Mycobacterium tuberculosis |
Q53845781 | [Laboratory diagnosis of mycobacterial infections] |
Q34298426 | rBCG30-induced immunity and cross-protection against Mycobacterium leprae challenge are enhanced by boosting with the Mycobacterium tuberculosis 30-kilodalton antigen 85B. |
Search more.